# 2022-02-28 What the record holds about this day. ## Became true - [Accenture](/record/accenture.md) | quarterly_net_income | 1,634,942,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_31A1916DE569](/claim/clm_31A1916DE569.md) | [clm_0F53D1D42526](/claim/clm_0F53D1D42526.md) - [Accenture](/record/accenture.md) | quarterly_operating_income | 2,061,580,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_D00A22828A16](/claim/clm_D00A22828A16.md) | [clm_333656E0883E](/claim/clm_333656E0883E.md) - [Accenture](/record/accenture.md) | total_assets | 44,317,837,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_4DBF122984BF](/claim/clm_4DBF122984BF.md) | [clm_44FCF641F76C](/claim/clm_44FCF641F76C.md) - [Accenture](/record/accenture.md) | quarterly_revenue | 15,046,693,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_17FEE4D2924D](/claim/clm_17FEE4D2924D.md) | [clm_7DE52993EEFD](/claim/clm_7DE52993EEFD.md) - [Accenture](/record/accenture.md) | total_equity | 20,560,023,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_26AAACBD0365](/claim/clm_26AAACBD0365.md) | [clm_8A97CC1157C3](/claim/clm_8A97CC1157C3.md) - [Accenture](/record/accenture.md) | cash_and_equivalents | 5,466,116,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_5073D31880DA](/claim/clm_5073D31880DA.md) | [clm_DD95169D6278](/claim/clm_DD95169D6278.md) - [Box](/record/box.md) | shares_outstanding | 143,423,689 shares | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_332283240F94](/claim/clm_332283240F94.md) | [clm_E5F22543498C](/claim/clm_E5F22543498C.md) - [DocuSign](/record/docusign.md) | shares_outstanding | 198,868,867 shares | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_C47C16D0BE00](/claim/clm_C47C16D0BE00.md) | [clm_73DD61C6966A](/claim/clm_73DD61C6966A.md) - [Elastic](/record/elastic.md) | shares_outstanding | 93,468,991 shares | valid 2022-02-28 to 2022-06-16 | conf 0.95 | superseded | superseded_by [clm_145065226161](/claim/clm_145065226161.md) | [clm_9FF287D1283A](/claim/clm_9FF287D1283A.md) - [Oracle Corporation](/record/oracle.md) | quarterly_revenue | 10,513,000,000 United States dollar | valid 2022-02-28 to 2022-08-31 | conf 0.95 | superseded | superseded_by [clm_B8EA8E786B80](/claim/clm_B8EA8E786B80.md) | [clm_191561C71112](/claim/clm_191561C71112.md) - [Oracle Corporation](/record/oracle.md) | total_equity | -8,696,000,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_99ABF981DC21](/claim/clm_99ABF981DC21.md) | [clm_6255E90FAD7E](/claim/clm_6255E90FAD7E.md) - [Oracle Corporation](/record/oracle.md) | quarterly_operating_income | 3,822,000,000 United States dollar | valid 2022-02-28 to 2022-08-31 | conf 0.95 | superseded | superseded_by [clm_AB006F34F807](/claim/clm_AB006F34F807.md) | [clm_8A5E43A98B77](/claim/clm_8A5E43A98B77.md) - [Oracle Corporation](/record/oracle.md) | quarterly_research_and_development | 1,816,000,000 United States dollar | valid 2022-02-28 to 2022-08-31 | conf 0.95 | superseded | superseded_by [clm_DCF353B62ABB](/claim/clm_DCF353B62ABB.md) | [clm_9026BB05B093](/claim/clm_9026BB05B093.md) - [Oracle Corporation](/record/oracle.md) | quarterly_net_income | 2,319,000,000 United States dollar | valid 2022-02-28 to 2022-08-31 | conf 0.95 | superseded | superseded_by [clm_11E8FC38F603](/claim/clm_11E8FC38F603.md) | [clm_95F1AEC620D0](/claim/clm_95F1AEC620D0.md) - [Oracle Corporation](/record/oracle.md) | cash_and_equivalents | 22,682,000,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_6338BADF9A1E](/claim/clm_6338BADF9A1E.md) | [clm_A87EE2270932](/claim/clm_A87EE2270932.md) - [Oracle Corporation](/record/oracle.md) | total_assets | 108,644,000,000 United States dollar | valid 2022-02-28 to 2022-05-31 | conf 0.95 | superseded | superseded_by [clm_381E3D39C91C](/claim/clm_381E3D39C91C.md) | [clm_DF9C6B7CFD9F](/claim/clm_DF9C6B7CFD9F.md) ## Stopped being true - [Accenture](/record/accenture.md) | cash_and_equivalents | 5,637,117,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_DD95169D6278](/claim/clm_DD95169D6278.md) | [clm_12FDFB40FFCF](/claim/clm_12FDFB40FFCF.md) - [Accenture](/record/accenture.md) | total_assets | 43,674,743,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_44FCF641F76C](/claim/clm_44FCF641F76C.md) | [clm_187A1D16AA1B](/claim/clm_187A1D16AA1B.md) - [Accenture](/record/accenture.md) | total_equity | 20,353,199,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_8A97CC1157C3](/claim/clm_8A97CC1157C3.md) | [clm_1FDC93AD3A7A](/claim/clm_1FDC93AD3A7A.md) - [Accenture](/record/accenture.md) | quarterly_net_income | 1,791,024,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_0F53D1D42526](/claim/clm_0F53D1D42526.md) | [clm_34638ED30963](/claim/clm_34638ED30963.md) - [Accenture](/record/accenture.md) | quarterly_revenue | 14,965,153,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_7DE52993EEFD](/claim/clm_7DE52993EEFD.md) | [clm_3BAF9032483A](/claim/clm_3BAF9032483A.md) - [Accenture](/record/accenture.md) | quarterly_operating_income | 2,434,294,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_333656E0883E](/claim/clm_333656E0883E.md) | [clm_F5C4FAD7EF98](/claim/clm_F5C4FAD7EF98.md) - [Box](/record/box.md) | shares_outstanding | 148,299,517 shares | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_E5F22543498C](/claim/clm_E5F22543498C.md) | [clm_548068035021](/claim/clm_548068035021.md) - [DocuSign](/record/docusign.md) | shares_outstanding | 197,876,523 shares | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_73DD61C6966A](/claim/clm_73DD61C6966A.md) | [clm_35A02320E9B6](/claim/clm_35A02320E9B6.md) - [Elastic](/record/elastic.md) | shares_outstanding | 92,613,879 shares | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_9FF287D1283A](/claim/clm_9FF287D1283A.md) | [clm_092583F4D353](/claim/clm_092583F4D353.md) - [Oracle Corporation](/record/oracle.md) | quarterly_research_and_development | 1,754,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_9026BB05B093](/claim/clm_9026BB05B093.md) | [clm_193802DB9782](/claim/clm_193802DB9782.md) - [Oracle Corporation](/record/oracle.md) | quarterly_net_income | -1,247,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_95F1AEC620D0](/claim/clm_95F1AEC620D0.md) | [clm_4D65E2DC98B5](/claim/clm_4D65E2DC98B5.md) - [Oracle Corporation](/record/oracle.md) | quarterly_operating_income | -824,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_8A5E43A98B77](/claim/clm_8A5E43A98B77.md) | [clm_4DCD62FC93D4](/claim/clm_4DCD62FC93D4.md) - [Oracle Corporation](/record/oracle.md) | cash_and_equivalents | 17,938,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_A87EE2270932](/claim/clm_A87EE2270932.md) | [clm_551E58C20E71](/claim/clm_551E58C20E71.md) - [Oracle Corporation](/record/oracle.md) | total_assets | 106,897,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_DF9C6B7CFD9F](/claim/clm_DF9C6B7CFD9F.md) | [clm_979C7955A541](/claim/clm_979C7955A541.md) - [Oracle Corporation](/record/oracle.md) | total_equity | -10,101,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_6255E90FAD7E](/claim/clm_6255E90FAD7E.md) | [clm_A132228AAB4D](/claim/clm_A132228AAB4D.md) - [Oracle Corporation](/record/oracle.md) | quarterly_revenue | 10,360,000,000 United States dollar | valid 2021-11-30 to 2022-02-28 | conf 0.95 | superseded | superseded_by [clm_191561C71112](/claim/clm_191561C71112.md) | [clm_A689B12AB9C7](/claim/clm_A689B12AB9C7.md) ## Recorded or changed on this day - none --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.